These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24184252)

  • 1. FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes.
    Pfister O; Lorenz V; Oikonomopoulos A; Xu L; Häuselmann SP; Mbah C; Kaufmann BA; Liao R; Wodnar-Filipowicz A; Kuster GM
    J Am Coll Cardiol; 2014 Mar; 63(10):1011-9. PubMed ID: 24184252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
    Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
    Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
    Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
    Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice.
    Ebelt H; Hillebrand I; Arlt S; Zhang Y; Kostin S; Neuhaus H; Müller-Werdan U; Schwarz E; Werdan K; Braun T
    Shock; 2013 Apr; 39(4):353-60. PubMed ID: 23376954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
    Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
    Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
    Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
    Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart.
    Wu X; Sagave J; Rutkovskiy A; Haugen F; Baysa A; Nygård S; Czibik G; Dahl CP; Gullestad L; Vaage J; Valen G
    Life Sci; 2014 Mar; 97(2):145-54. PubMed ID: 24398041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin improved ventricular function and regulated remodeling genes in a rat model of myocardial infarction.
    Chan KY; Zhou L; Xiang P; Li K; Ng PC; Wang CC; Li M; Pong NH; Tu L; Deng H; Kong CK; Sung RY
    Int J Cardiol; 2013 Sep; 167(6):2546-54. PubMed ID: 22770769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction.
    Joki Y; Ohashi K; Yuasa D; Shibata R; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ito M; Ogawa H; Daida H; Murohara T; Ouchi N
    Circ Heart Fail; 2015 Mar; 8(2):342-51. PubMed ID: 25654972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis.
    Takada Y; Hashimoto M; Kasahara J; Aihara K; Fukunaga K
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1249-55. PubMed ID: 15292457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
    Kanamori H; Takemura G; Goto K; Tsujimoto A; Ogino A; Takeyama T; Kawaguchi T; Watanabe T; Morishita K; Kawasaki M; Mikami A; Fujiwara T; Fujiwara H; Seishima M; Minatoguchi S
    Am J Pathol; 2013 Mar; 182(3):701-13. PubMed ID: 23274061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered melusin pathways involved in cardiac remodeling following acute myocardial infarction.
    Gu R; Zheng D; Bai J; Xie J; Dai Q; Xu B
    Cardiovasc Pathol; 2012; 21(2):105-11. PubMed ID: 21546274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.
    Ren J; Zhang S; Kovacs A; Wang Y; Muslin AJ
    J Mol Cell Cardiol; 2005 Apr; 38(4):617-23. PubMed ID: 15808838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated expression of plasminogen activator inhibitor-1 augments myocardial neovascularization and reduces cardiomyocyte apoptosis after acute myocardial infarction.
    Xiang G; Schuster MD; Seki T; Witkowski P; Eshghi S; Itescu S
    J Am Coll Cardiol; 2005 Aug; 46(3):536-41. PubMed ID: 16053971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
    Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.